Development of a simple, biocompatible and cost-effective Inulin-Diethylenetriamine based siRNA delivery system

European Journal of Pharmaceutical Sciences

Volumn 75, Issue , 2015, Pages 60-71

  Sardo, C ^a   Farra, R ^b   Licciardi, M ^a   Dapas, B ^c   Scialabba, C ^a   Giammona, G ^a   Grassi, M ^b   Grassi, G ^c   Cavallaro, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

16HBE; Diethylenetriamine (DETA); Inu DETA copolymer; Inulin; JHH6; siRNA

Indexed keywords

DIETHYLENETRIAMINE; ETHYLENEDIAMINE; INULIN; SMALL INTERFERING RNA; E2F1 PROTEIN, HUMAN; POLYAMINE; TRANSCRIPTION FACTOR E2F1;

ACIDIFICATION; ARTICLE; BIOCOMPATIBILITY; CARCINOMA CELL; CELL MEMBRANE; CELL PROLIFERATION; CELL VIABILITY; CONJUGATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOPLASM VESICLE; DRUG DELIVERY SYSTEM; ELECTROPHORESIS; ENDOCYTOSIS; EPITHELIUM CELL; HEATING; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MICROWAVE IRRADIATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PROTON TRANSPORT; REACTION TIME; SURFACE CHARGE; SYNTHESIS; THERMODYNAMICS; ZETA POTENTIAL; CELL LINE; CHEMISTRY; GENETICS; TUMOR CELL LINE;

CELL LINE; CELL LINE, TUMOR; E2F1 TRANSCRIPTION FACTOR; ENDOCYTOSIS; HUMANS; INULIN; POLYAMINES; RNA, SMALL INTERFERING;

EID: 84929955000     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2015.03.021     Document Type: Article

References (42)

1. F. Agostini, B. Dapas, R. Farra, M. Grassi, G. Racchi, K. Klingel, R. Kandolf, O. Heidenreich, A. Mercatahnti, G. Rainaldi, F. Altamura, G. Guarnieri, and G. Grassi Potential applications of small interfering RNAs in the cardiovascular field Drug Future 31 2006 513 525
2. N. Araki, M.T. Johnson, and J.A. Swanson A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages J. Cell Biol. 135 1996 1249 1260
3. D. Baiz, B. Dapas, R. Farra, B. Scaggiante, G. Pozzato, F. Zanconati, N. Fiotti, L. Consoloni, S. Chiaretti, and G. Grassi Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines World J. Gastroenterol. 20 2014 795 803
4. B. Ballarin-Gonzalez, and K.A. Howard Polycation-based nanoparticle delivery of RNAi therapeutics: adverse effects and solutions Adv. Drug Deliv. Rev. 64 2012 1717 1729
5. S. Boeckle, G.K. von, S. van der Piepen, C. Culmsee, E. Wagner, and M. Ogris Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer J. Gene Med. 6 2004 1102 1111
6. M.D. Brown, A.G. Schatzlein, and I.F. Uchegbu Gene delivery with synthetic (non viral) carriers Int. J. Pharm. 229 2001 1 21
7. K. Bruno Using drug-excipient interactions for siRNA delivery Adv. Drug Deliv. Rev. 63 2011 1210 1226
8. G. Cavallaro, M. Licciardi, G. Amato, C. Sardo, G. Giammona, R. Farra, B. Dapas, M. Grassi, and G. Grassi Synthesis and characterization of polyaspartamide copolymers obtained by ATRP for nucleic acid delivery Int. J. Pharm. 466 2014 246 257
9. G. Cavallaro, M. Licciardi, S. Scire, and G. Giammona Microwave-assisted synthesis of PHEA-oligoamine copolymers as potential gene delivery systems Nanomedicine (Lond) 4 2009 291 303
10. B. Dapas, R. Farra, M. Grassi, C. Giansante, N. Fiotti, L. Uxa, G. Rainaldi, A. Mercatanti, A. Colombatti, P. Spessotto, V. Lacovich, G. Guarnieri, and G. Grassi Role of E2F1-cyclin E1-cyclin E2 circuit in human coronary smooth muscle cell proliferation and therapeutic potential of its downregulation by siRNAs Mol. Med. 15 2009 297 306
11. Y. Deng, C.C. Wang, K.W. Choy, Q. Du, J. Chen, Q. Wang, L. Li, T.K. Chung, and T. Tang Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies Gene 538 2014 217 227
12. N. Denora, V. Laquintana, A. Lopalco, R.M. Iacobazzi, A. Lopedota, A. Cutrignelli, G. Iacobellis, C. Annese, M. Cascione, S. Leporatti, and M. Franco In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer J. Control. Release 172 2013 1111 1125
13. A. El-Sayed, and H. Harashima Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis Mol. Ther. 21 2013 1118 1130
14. R. Farra, B. Dapas, G. Pozzato, C. Giansante, O. Heidenreich, L. Uxa, C. Zennaro, G. Guarnieri, and G. Grassi Serum response factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 Biochimie 92 2010 455 463
15. R. Farra, B. Dapas, G. Pozzato, B. Scaggiante, F. Agostini, C. Zennaro, M. Grassi, N. Rosso, C. Giansante, N. Fiotti, and G. Grassi Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells Dig. Liver Dis. 43 2011 1006 1014
16. D. Fischer, T. Bieber, Y. Li, H.P. Elsasser, and T. Kissel A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity Pharm. Res. 16 1999 1273 1279
17. D. Fischer, Y. Li, B. Ahlemeyer, J. Krieglstein, and T. Kissel In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis Biomaterials 24 2003 1121 1131
18. G. Grassi, R. Farra, E. Noro, D. Voinovivh, R. Lapasin, B. Dapas, O. Alpar, C. Zennaro, M. Carraro, C. Giansante, G. Guarnieri, A. Pascotto, B. Reihmers, and M. Grassi Charactherization of nucleid acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices J. Drug Deliv. Sci. Technol. 17 2007 325 331
19. G. Grassi, B. Scaggiante, B. Dapas, R. Farra, F. Tonon, G. Lamberti, A. Barba, S. Fiorentino, N. Fiotti, F. Zanconati, M. Abrami, and M. Grassi Therapeutic potential of nucleic acid-based drugs in coronary hyper-proliferative vascular diseases Curr. Med. Chem. 20 2013 3515 3538
20. M. Grassi, G. Cavallaro, S. Scirè, B. Scaggiante, B. Daps, R. Farra, D. Baiz, C. Giansante, G. Guarnieri, D. Perin, and G. Grassi Current strategies to improve the efficacy and the delivery of nucleic acid based drugs Curr. Signal Transduct. Ther. 5 2010 92 120
21. Hayes, B. L., Collins, M. Reactions and temperature control for high power microwave-assisted chemistry techniques. [World Patent WO 04002617]. 2004.
22. Y. Kaneda Gene therapy: a battle against biological barriers Curr. Mol. Med. 1 2001 493 499
23. C.X. Li, A. Parker, E. Menocal, S. Xiang, L. Borodyansky, and J.H. Fruehauf Delivery of RNA interference Cell Cycle 5 2006 2103 2109
24. X.H. Luo, F.W. Huang, S.Y. Qin, H.F. Wang, J. Feng, X.Z. Zhang, and R.X. Zhuo A strategy to improve serum-tolerant transfection activity of polycation vectors by surface hydroxylation Biomaterials 32 2011 9925 9939
25. O.M. Merkel, and T. Kissel Quo vadis polyplex? J. Control. Release 190 2014 415 423
26. K. Miyata, M. Oba, M. Nakanishi, S. Fukushima, Y. Yamasaki, H. Koyama, N. Nishiyama, and K. Kataoka Polyplexes from poly(aspartamide) bearing 1,2-diaminoethane side chains induce pH-selective, endosomal membrane destabilization with amplified transfection and negligible cytotoxicity J. Am. Chem. Soc. 130 2008 16287 16294
27. E. Montemayor Biochemical studies of spermidine/spermine N1-acetyltransferase, an important regulator of cellular polyamines ProQuest 2008
28. Y.K. Oh, and T.G. Park SiRNA delivery systems for cancer treatment Adv. Drug Deliv. Rev. 61 2009 850 862
29. G. Racchi, K. Klingel, R. Kandolf, and G. Grassi Targeting of protease 2A genome by single and multiple siRNAs as a strategy to impair CVB3 life cycle in permissive HeLa cells Methods Find. Exp. Clin. Pharmacol. 31 2009 63 70
30. J. Rejman, A. Bragonzi, and M. Conese Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes Mol. Ther. 12 2005 468 474
31. J. Rejman, V. Oberle, I.S. Zuhorn, and D. Hoekstra Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis Biochem. J. 377 2004 159 169
32. P. Resnier, T. Montier, V. Mathieu, J.P. Benoit, and C. Passirani A review of the current status of siRNA nanomedicines in the treatment of cancer Biomaterials 34 2013 6429 6443
33. C. Sardo, E. Craparo, C. Fiorica, G. Giammona, and G. Cavallaro Inulin derivatives obtained via enhanced microwave synthesis for nucleic acid based drugs Curr. Drug Targets 2014 (in press)
34. B. Scaggiante, B. Dapas, R. Farra, M. Grassi, G. Pozzato, C. Giansante, N. Fiotti, and G. Grassi Improving siRNA bio-distribution and minimizing side effects Curr. Drug Metab. 12 2011 11 23
35. C. Scialabba, M. Licciardi, N. Mauro, F. Rocco, M. Ceruti, and G. Giammona Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy Eur. J. Pharm. Biopharm. 2014
36. V. Singha, P. Kumara, and R. Sanghi Use of microwave irradiation in the grafting modification of the polysaccharides - a review Prog. Polym. Sci. 37 2012 340 364 (Ref Type: Journal (Full))
37. S. Spagnou, A.D. Miller, and M. Keller Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA Biochemistry 43 2004 13348 13356
38. A.K. Varkouhi, M. Scholte, G. Storm, and H.J. Haisma Endosomal escape pathways for delivery of biologicals J. Control. Release 151 2011 220 228
39. D. Vercauteren, J. Rejman, T.F. Martens, J. Demeester, S.C. De Smedt, and K. Braeckmans On the cellular processing of non-viral nanomedicines for nucleic acid delivery: mechanisms and methods J. Control. Release 161 2012 566 581
40. D. Werth, G. Grassi, N. Konjer, B. Dapas, R. Farra, C. Giansante, R. Kandolf, G. Guarnieri, A. Nordheim, and O. Heidenreich Proliferation of human primary vascular smooth muscle cells depends on serum response factor Eur. J. Cell Biol. 89 2010 216 224
41. S. Xiang, H. Tong, Q. Shi, J.C. Fernandes, T. Jin, K. Dai, and X. Zhang Uptake mechanisms of non-viral gene delivery J. Control. Release 158 2012 371 378
42. S. Zhang, B. Zhao, H. Jiang, B. Wang, and B. Ma Cationic lipids and polymers mediated vectors for delivery of siRNA J. Control. Release 123 2007 1 10